# eMedClub

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/emedclub

- Industry: Media
- Headquarters: Shanghai, China
- Website: www.emedclub.sxl.cn
- Latest round: Series A (Oct 11, 2021)
- Investors on record: 4

## About

Established in 2016 and based in Shanghai, China, eMedClub is a biomedical content provider that engages in providing biotechnology information such as cell and gene therapy. In 2017, the company changed its name from Cell Culture Club to eMedClub.

The company focuses on providing biotechnology information. The biotechnology information provided by the company includes cell and gene therapy (CAR-T/NK, TIL, AAV, OV, LV), new antibody drugs (Nanobody, bsAbs, ADC), stem cells and regenerative medicine (MSC, iPSC, organoids and 3D culture) and gene editing, etc. It has platforms such as medical class, medicine financing and medical school.

## Funding rounds

- Series A, Oct 11, 2021 — FOF Capital, HiMed Angle Fund Management, Shileng Investment, Longjin Investment

## Investors

- FOF Capital (https://capitalatlas.ai/funds/fof-capital) — Series A
- HiMed Angle Fund Management (https://capitalatlas.ai/funds/himed-angle-fund-management) — Series A
- Shileng Investment (https://capitalatlas.ai/funds/shileng-investment) — Series A
- Longjin Investment — Series A